Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : NVO    crawled time : 11:00    save search

Novo Nordisk A/S - share repurchase programme
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.96% H: 1.3% C: 1.13%

repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2024-02-26 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.78% C: 0.24%

repurchase
Novo Nordisk to acquire three fill-finish sites from Novo Holdings A/S in connection with the Catalent, Inc. transaction
Published: 2024-02-05 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 2.37% H: 1.9% C: 1.61%
CTLT | $55.8 -0.29% 0.0% 1M twitter stocktwits trandingview |
Health Technology
| | O: 8.81% H: 1.5% C: 0.86%

acquire
Novo Nordisk A/S - share repurchase programme
Published: 2024-01-15 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2024-01-08 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.19% H: 0.34% C: 0.21%

repurchase
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
Published: 2024-01-04 (Crawled : 11:00) - globenewswire.com
OMGA | $2.42 -5.28% -5.58% 360K twitter stocktwits trandingview |
| | O: 92.31% H: 20.0% C: 1.24%
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.44% H: 3.68% C: 2.4%

treatment research therapeutics
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-11-14 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.07% H: 0.09% C: -0.5%


Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences
Published: 2023-10-16 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.19% C: -0.13%

acquire hypertension
Novo Nordisk A/S - share repurchase programme
Published: 2023-10-09 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.07% H: 1.15% C: 1.02%

repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2023-07-03 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.05% H: 0.0% C: -0.44%

repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2023-06-12 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.35% H: 0.22% C: -0.89%

repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2023-05-30 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.72% H: 0.02% C: -1.23%

repurchase
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-05-10 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.81% H: 1.55% C: 1.34%


Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2023-02-08 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.85% H: 0.09% C: -0.85%


Diabetes Therapeutics Market Worth $91+ Billion, Globally, by 2028 at 6+% CAGR | The Insight Partners
Published: 2022-10-19 (Crawled : 11:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: -1.98% H: 0.0% C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.18% H: 0.56% C: -1.11%
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 0.04% C: -1.58%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 0.06% C: -0.75%
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.96% H: 0.22% C: -0.76%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: -1.37% H: 0.0% C: 0.0%

therapeutics diabetes market
Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program
Published: 2022-09-29 (Crawled : 11:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.05% H: 0.51% C: -0.01%

program license therapeutics agreement
Second Innate Pharma NK Cell Engager Selected by Sanofi as Drug Candidate for Development
Published: 2022-07-21 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: -2.38% H: 0.0% C: 0.0%
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.28% H: 1.56% C: 1.39%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: -3.38% H: 0.0% C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -2.56%

pharma drug candidate sanofi
Novo Nordisk A/S – Share repurchase programme
Published: 2022-07-18 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.43% H: 1.11% C: -1.28%

repurchase
Novo Nordisk A/S – Share repurchase programme
Published: 2022-07-11 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.18% H: 1.24% C: 0.45%

repurchase
Global Clinical Trials Markets 2022-2028: Globalization of Clinical Trials / Increasing R&D Promoting Outsourcing / Adoption of New Technology in Clinical Research
Published: 2022-06-28 (Crawled : 11:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M twitter stocktwits trandingview |
Health Technology
| | O: -2.98% H: 0.66% C: -0.87%
LLY | $745.95 -0.64% -0.1% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%
ICLR | $291.74 -0.1% -0.1% 500K twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.96% C: -0.24%

trials research technology trial
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.